Kefir, Gut Microbiota, and Athletic Performance in Soccer Players
Launched by ACIBADEM UNIVERSITY · Dec 30, 2024
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
This randomized controlled trial aims at evaluating the impact of kefir on the participants' gut microbiota and athletic performance among professional female soccer players of 18-29 years. The present study is intended to reveal the potential of kefir, a fermented milk product that is packed with probiotics , in altering the diversity and profile of gut microbiota, physical performance, and parameters of body composition.
This trial was carried out for a period of four weeks and the subjects were divided into two parallel groups; the kefir group in which the participants consume 200ml of ...
Gender
FEMALE
Eligibility criteria
- Inclusion criteria:
- • Professional female soccer player
- • Aged between 18 and 35 years
- • Regular participation in a structured training program
- • No allergy or intolerance to kefir or dairy products
- • Willingness to voluntarily participate in the study
- • Signed informed consent form
- Exclusion criteria:
- • History of allergy or intolerance to kefir or dairy products
- • Presence of chronic diseases (e.g., diabetes, heart disease, kidney failure)
- • Use of antibiotics or probiotic supplements within the last 3 months
- • Pregnancy or breastfeeding
- • Inability to comply with the study protocol
About Acibadem University
Acibadem University is a leading academic institution in Turkey, dedicated to advancing medical education, research, and healthcare innovation. With a focus on interdisciplinary collaboration, the university conducts cutting-edge clinical trials that aim to enhance patient outcomes and contribute to the global body of medical knowledge. Leveraging state-of-the-art facilities and a robust network of healthcare professionals, Acibadem University fosters an environment of excellence in clinical research, ensuring adherence to the highest ethical standards and regulatory compliance. Through its commitment to scientific discovery and education, the university plays a pivotal role in shaping the future of healthcare both nationally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, , Turkey
Patients applied
Trial Officials
Duygu Sağlam, Associate Professor
Study Chair
Acibadem University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported